Congenital heart block associated with undiagnosed maternal Primary Sjögren's Syndrome - A case report and discussion

Oral Diseases

Volumn 11, Issue 3, 2005, Pages 190-192

  Steele, J C ^a   Dawson, L J ^a   Moots, R J ^b   Field, E A ^a  

^a LIVERPOOL UNIVERSITY DENTAL HOSPITAL   (United Kingdom)

^b University Hospitals Aintree   (United Kingdom)

Author keywords

Congenital; Heart block; Sj gren's Syndrome

Indexed keywords

CALCIUM CHANNEL L TYPE; CYCLOSPORIN; RO ANTIBODY; THYROXINE;

ADULT; ARTICLE; CONGENITAL HEART BLOCK; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; MATERNAL DISEASE; NEWBORN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIALOADENITIS; SJOEGREN SYNDROME;

EID: 20144378750     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01050.x     Document Type: Article

References (20)

1. Borda E, Sterin-Borda L (2001). Autoantibodies against neonatal heart M1 muscarinic acetylcholine receptor in children with congenital heart block. J Autoimmun 16: 143-150.
2. Borda E, Camusso JJ, Leiroz CP et al (1996). Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjögren's syndrome. Molecular and Cellular Biochemistry 163/164: 335-341.
3. Borda E, Leiros CP, Bacman S et al (1999). Sjögren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation. Int J Cardiol 70: 23-32.
4. Boutjdir M, Chen L, Zhang ZH et al (1997). Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res 80: 354-362.
5. Brucato A, Frassi M, Franceschini F et al (2001). Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 44: 1832-1835.
6. Gordon PA, Khamashta MA, Hughes GR et al (2001). A normal ECG at birth does not exclude significant congenital cardiac conduction disease associated with maternal anti-Ro antibodies. Rheumatology (Oxford) 40: 939-940.
7. Ho SY, Esscher E, Anderson RH et al (1986). Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol 58: 291-294.
8. Hoerter JA, Vassort G (1982). Participation of the sarcolemma in the control of relaxation of the mammalian heart during perinatal development. Adv Myocardiol 3: 373-380.
9. Julkunen H, Eronen M (2001). Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis & Rheumatism 44: 647-652.
10. Li J-M, Fan WS, Horsfall AC et al (1996). The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block. Clin Exp Immunol 104: 388-393.
11. Mazel JA, El-Sherif N, Buyon J et al (1999). Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 99: 1914-1918.
12. McCue CM, Mantakas ME, Tingelstad JB et al (1977). Congenital heart block in newborns of mothers with connective tissue disease. Circulation 56: 82-90.
13. Michaelson M, Engle MA (1972). Congenital heart block: an international study of the natural history. Cardiovasc Clin 4: 75-101.
14. Miranda ME, Tseng CE, Rashbaum W et al (1998). Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 161: 5061-5069.
15. Miranda-Carus ME, Boutjdir M, Tseng CE et al (1998). Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J Immunol 161: 5886-5892.
16. Miranda-Carus ME, Askanase AD, Clancy RM et al (2000). Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 165: 5345-5351.
17. Theander E, Brucato A, Gudmundsson S et al (2001). Primary Sjögren's Syndrome - treatment of fetal incomplete atrioventricular block with dexamethasone. J Rheumatol 28: 373-376.
18. Valdini LM, Sreebny A (1987). Xerostomia: a neglected symptom. Arch Intern Med 147: 1333-1337.
19. Vitali C, Bombardieri S, Jonsson R et al (2002). Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558.
20. Xiao GQ, Hu K, Boutjdir M (2001). Direct inhibition of expressed cardiac 1- and t-type calcium channels by IgG from mothers whose children have congenital heart block. Circulation 103: 1599-1604.